Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oxidative stress contributes to hair graying and loss as we age.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

People with alopecia areata have a higher risk of stroke.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.